Pulmonx Common Stock share price logo

Pulmonx Common Stock

NASDAQ: LUNG

Small Cap

$1.40

+0.11

(+8.98%)

as on

Pulmonx Common Stock Stock Performance

as on June 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.28
    $1.42
    downward going graph

    8.57%

    Downside

    1.43%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.13
    $3.88
    downward going graph

    19.29%

    Downside

    177.14%

    Upside

    downward going graph

Pulmonx Common Stock share price movements today

Previous Close
$1.28
Open
$1.31
Volume
570.6K
Day's Low - High
$1.28 - $1.42
52 Week Low - High
$1.13 - $3.88

Pulmonx Common Stock Historical Returns

1 Month Return
-17.42 %
3 Month Return
-2.29 %
1 Year Return
-52.5 %
3 Year Return
-90.06 %
5 Year Return
-97.06 %

Pulmonx Common Stock Stock Fundamentals & Key Indicators

Check Pulmonx Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$54.1M

EPS (TTM)

-1.142

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-51.2M

Revenue (TTM)

88.5M

Profit Margin

-60.09%

Return On Equity TTM

-86.22%

Pulmonx Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pulmonx Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$54.1M-97.06%NA-60.09%NA
BUY$116.8B18.6%35.2213.21%1.1199999999999999%
BUY$49.4B-16.23%46.4217.39%NA
BUY$101.5B-35.54%21.2513.20%3.58%
BUY$65.9B4.32%18.5517.29%NA

Stock Returns calculator for Pulmonx Common Stock Stock including INR - Dollar returns

The Pulmonx Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pulmonx Common Stock investment value today

Current value as on today

₹57,326

Returns

-₹42,674

(-42.67%)

Returns from Pulmonx Common Stock Stock

-₹47,955 (-47.96%)

Dollar Impact

₹5,281 (+5.28%)

Analyst Recommendation on Pulmonx Common Stock Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Pulmonx Common Stock. Average target price of $3.4

Pulmonx Common Stock Share Price Target

Get share price movements and forecasts by analysts on Pulmonx Common Stock.

What analysts predicted

58.82%UPSIDE

Target Price

$3.4

Current Price

$1.4

Analyzed by

11 Analysts

Target

$3.40

Pulmonx Common Stock target price $3.4, a slight upside of 58.82% compared to current price of $1.4. According to 11 analysts rating.

Indian Investors' Interest in Pulmonx Common Stock Stock

Search interest for Pulmonx Common Stock Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-6% versus previous 30 day period

Pulmonx Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
19
18
20
20
23
22
23
21
22
20
Gross Profit
14
13
15
15
17
16
17
16
17
16
Operating Income
-13
-14
-15
-14
-13
-14
-14
-14
-9
-12
EBITDA
-12
-12
-13
-12
-12
-14
-13
-12
-9
-12
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-13
-15
-13
-13
-14
-14
-13
-10
-13
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-13
-13
-15
-14
-13
-14
-15
-13
-10
-13
Net Profit Margin
-72.04%
-72.92%
-73.74%
-69.38%
-55.44%
-64.11%
-63.59%
-64.91%
-46.13%
-66.33%

Pulmonx Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
-
20
32
32
48
53
68
83
90
Gross Profit
0
-
12
22
21
35
39
50
62
67
Operating Income
-2
-5
-15
-17
-32
-47
-58
-61
-57
-53
EBITDA
-
-
-15
-16
-28
-46
-55
-55
-50
-49
Interest Expense
-
-
2
2
3
0
1
3
3
3
Depreciation
-
-
0
0
0
0
1
1
1
1
Income Before Tax
-2
-5
-18
-20
-32
-48
-58
-60
-55
-53
Income Tax Expense
-
-
0
0
0
0
0
0
0
0
Net Income
-2
-5
-18
-20
-32
-48
-58
-60
-56
-54
Net Profit Margin
-31539.27%
0.00%
-92.38%
-63.52%
-98.47%
-100.51%
-109.80%
-88.60%
-67.30%
-59.67%

Pulmonx Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-13
-15
-14
-13
-14
-15
-13
-10
-13
Operating Cash Flow
-11
-5
-7
-6
-13
-3
-8
-7
-10
Investing Cash Flow
-2
0
6
14
16
5
8
0
0
Financing Cash Flow
0
0
0
0
0
0
0
0
2
Change in Cash
-13
-6
0
7
3
0
1
-6
-8

Pulmonx Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-5
-18
-20
-32
-48
-58
-60
-56
-54
Operating Cash Flow
-4
-18
-20
-30
-41
-45
-37
-31
-32
Investing Cash Flow
0
0
-14
12
-46
-4
-2
17
30
Financing Cash Flow
5
12
45
234
4
2
21
1
0
Change in Cash
0
-5
10
217
-83
-46
-18
-12
-1

Global Institutional Holdings in Pulmonx Common Stock

Funds
Holdings
Dimensional Fund Advisors, Inc.
1.12%
Northern Trust Corp
0.84%
ExodusPoint Capital Management, LP
4.6%
Renaissance Technologies Corp
0.76%
BRAIDWELL LP
1.78%

Insights on Pulmonx Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 14.6% return, outperforming this stock by 67.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Pulmonx Corporation Common Stock has experienced a drawdown of -90.1%, however Stryker Corporation resisted the overall trend and outperformed by 86.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 22.59M → 20.58M (in $), with an average decrease of 8.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -10.42M → -13.65M (in $), with an average decrease of 31.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, LUNG stock has moved down by -90.1%

About Pulmonx Common Stock

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
OrganisationPulmonx Common Stock
Headquarters700 Chesapeake Drive, Redwood City, CA, United States, 94063
IndustryMedical Devices
CEOMr. Glendon E. French
E-voting on sharesClick here to vote

Key Management of Pulmonx Common Stock

Name

Title

Mr. Glendon E. French

CEO, President & Director

Dr. Derrick Sung Ph.D.

CFO & COO

Mr. Srikanth Radhakrishnan

Chief Science & Technology Officer

Ms. Marcee M. Maroney

Vice President of Marketing

Mr. John B. McKune

VP of Finance & Corporate Controller

Mr. David A. Lehman J.D.

General Counsel & Secretary

Ms. Lisa Paul

Chief People Officer

Mr. Jérôme Erath

Senior VP & GM of International

Mr. Geoffrey Beran Rose

Chief Commercial Officer

Dr. Narinder S. Shargill Ph.D.

Senior Vice President of Global Medical & Clinical Affairs

FAQs

What is Pulmonx Common Stock share price today?

Pulmonx Common Stock share price today is $1.4 as on at the close of the market. Pulmonx Common Stock share today touched a day high of $1.42 and a low of $1.28.

What is the 52 week high and 52 week low for Pulmonx Common Stock share?

Pulmonx Common Stock share touched a 52 week high of $3.88 on and a 52 week low of $1.13 on . Pulmonx Common Stock stock price today i.e. is closed at $1.4,which is 63.92% down from its 52 week high and 23.89% up from its 52 week low.

What is Pulmonx Common Stock's market capitalisation today?

Pulmonx Common Stock market capitalisation is $0.00T as on .

How to invest in Pulmonx Common Stock Stock (LUNG) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pulmonx Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pulmonx Common Stock Shares that will get you 1.0714 shares as per Pulmonx Common Stock share price of $1.4 per share as on June 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Pulmonx Common Stock Stock (LUNG) from India?

Indian investors can start investing in Pulmonx Common Stock (LUNG) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in Pulmonx Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Pulmonx Common Stock share’s latest price of $1.4 as on June 25, 2026 at 1:29 am IST, you will get 7.1429 shares of Pulmonx Common Stock. Learn more about fractional shares .

What are the returns that Pulmonx Common Stock has given to Indian investors in the last 5 years?

Pulmonx Common Stock stock has given -97.06% share price returns and 27.62% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?